An advantageous synthesis of new indazolone and pyrazolone derivatives

Tetrahedron

Volumn 62, Issue 48, 2006, Pages 11100-11105

  Correa, Arkaitz ^a   Tellitu, Imanol ^a   Domínguez, Esther ^a   SanMartin, Raul ^a  

^a UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

Author keywords

Hypervalent iodine; Indazolone; N Acylnitrenium; Pyrazolone

Indexed keywords

2 (4 METHOXYPHENYL) 1 PHENYL 1,2 DIHYDRO 3H INDAZOL 3 ONE; 2 (4 METHOXYPHENYL) 1 PHENYLPYRAZOL 3 ONE; 4 CHLORO N (4 METHOXYPHENYL) 2 PHENYLAMINOBENZAMIDE; 4 CYANO N (4 METHOXYPHENYL) 3 PHENYLAMINOTHIOPHENE 2 CARBOXAMIDE; 4,5 DIMETHOXY N (4 METHOXYPHENYL) 2 PHENYLAMINOBENZAMIDE; 5 FLUORO 2 (4 METHOXYPHENYL) 1 PHENYL 1,2 DIHYDRO 3H INDAZOL 3 ONE; 5 FLUORO N (4 METHOXYPHENYL) 2 PHENYLAMINOBENZAMIDE; 6 CHLORO 2 (4 METHOXYPHENYL) 1 PHENYL 1,2 DIHYDRO 3H INDAZOL 3 ONE; 6 CYANO 2 (4 METHOXYPHENYL) 1 PHENYLTHIENO[3,2 C]PYRAZOL 3 ONE; AMINE; ANTHRANILIC ACID; AROMATIC AMIDE; IODINE; METHYL 3 PHENYLAMINOTHIOPHENE 2 CARBOXYLATE; METHYL 4 CHLOROPHENYLAMINOBENZOATE; METHYL 4 CYANO 3 PHENYLAMINOTHIOPHENE 2 CARBOXYLATE; METHYL 4,5 DIMETHOXY 2 PHENYLAMINOBENZOATE; METHYL 5 FLUORO 2 PHENYLAMINOBENZOATE; METHYL N PHENYLANTHRANILATE; N (4 METHOXYPHENYL) 2 PHENYLAMINOBENZAMIDE; N (4 METHOXYPHENYL) 3 PHENYLAMINOPROPIONAMIDE; N (4 METHOXYPHENYL) 3 PHENYLAMINOTHIOPHENE 2 CARBOXAMIDE; NITRIC ACID DERIVATIVE; PYRAZOLONE; PYRAZOLONE DERIVATIVE; REAGENT; UNCLASSIFIED DRUG;

ARTICLE; CHEMICAL BOND; DRUG STRUCTURE; DRUG SYNTHESIS; OXIDATION; PRIORITY JOURNAL;

EID: 33750017828     PISSN: 00404020     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tet.2006.09.031     Document Type: Article

References (54)

1. Rahman A.-U., Malik S., Cun-heng H., and Clardy J. Tetrahedron Lett. 26 (1985) 2759-2762
2. Rahman A.-U., Malik S., Hasan S.S., Choudhary M.I., Ni C.-Z., and Clardy J. Tetrahedron Lett. 36 (1995) 1993-1996
3. ®, exhibits analgesic, antiinflammatory and antimicrobial activities. See, for example:
4. Lisciani R., Barcellona P.S., and Silvestrini B. Eur. J. Pharmacol. 3 (1968) 157-162
5. White B.A., Lockhart P.B., Connolly S.F., and Sonis S.T. Int. J. Tissue React. 9 (1987) 105-114
6. Modéer T., and Yucel-Lindberg T. Acta Odontol. Scand. 57 (1999) 40-45
7. Tse E., Butner L., Huang Y., and Hall I.H. Arch. Pharm. Pharm. Med. Chem. 329 (1996) 35-40
8. Abouzid K.A.M., and El-Abhar H.S. Arch. Pharm. Res. 26 (2003) 1-8
9. Badawey E.-S.A.M., and El-Ashmawey I.M. Eur. J. Med. Chem. 33 (1998) 349-361
10. El-Hawash S.A.M., Badawey E.-S.A.M., and El-Ashmawey I.M. Eur. J. Med. Chem. 41 (2006) 155-165
11. Fletcher S.R., McIver E., Lewis S., Burkamp F., Leech C., Mason G., Boyce S., Morrison D., Richards G., Sutton K., and Jones A.B. Bioorg. Med. Chem. Lett. 16 (2006) 2872-2876
12. McBride C.M., Renhowe P.A., Gesner T.G., Jansen J.M., Lin J., Ma S., Zhou Y., and Shafer C.M. Bioorg. Med. Chem. Lett. 16 (2006) 3789-3792
13. Wyrick S.D., Voorstad P.J., Cocolas G., and Hall I.H. J. Med. Chem. 27 (1984) 768-772
14. See for example:
15. Clark M.P., Laughlin S.K., Laufersweineiler M.J., Bookland R.G., Brugel T.A., Golebiowski A., Sabat M.P., Townes J.A., VanRens J.C., Djung J.F., Natchus M.G., De B., Hsieh L.C., Xu S.C., Walter R.L., Mekel M.J., Heitmeyer S.A., Brown K.K., Juergens K., Taiwo Y.O., and Janusz M.J. J. Med. Chem. 47 (2004) 2724-2727
16. Golebiowski A., Townes J.A., Laufersweiler M.J., Brugel T.A., Clarck M.P., Clarck C.M., Djung J.F., Laughlin S.K., Sabat M.P., Bookland R.G., VanRens J.C., De B., Hsieh L.C., Janusz M.J., Walter R.L., Webster M.E., and Mekel M.J. Bioorg. Med. Chem. Lett. 15 (2005) 2285-2289
17. See, for example:
18. Murahashi S., and Horiie S. J. Am. Chem. Soc. 78 (1956) 4816-4817
19. Barton D.H.R., Lukacs G., and Wagle D. J. Chem. Soc., Chem. Commun. (1982) 450-452
20. Bird C.W., Chng J.C.W., Rama N.H., and Saeed A. Synth. Commun. 21 (1991) 545-548
21. Bruneau P., and Delvare C. J. Med. Chem. 34 (1991) 1028-1036
22. Zhou D.-Y., Koike T., Suetsugu S., Onitsuka K., and Takahashi S. Inorg. Chim. Acta 357 (2004) 3057-3063
23. Laufersweiler M.J., Brugel T.A., Clarck M.P., Golebiowski A., Bookland R.G., Laughlin S.K., Sabat M.P., Townes J.A., VanRens J.C., De B., Hsieh L.C., Heitmeyer S.A., Juergens K., Brown K.K., Mekel M.J., Walter R.L., and Janusz M.J. Bioorg. Med. Chem. Lett. 14 (2004) 4267-4272
24. Kurth M.J., Olmstead M.M., and Haddadin M.J. J. Org. Chem. 70 (2005) 1060-1062
25. For recent reviews on the synthetic applications of polyvalent iodine reagents, see:
26. Zhdankin V.V., and Stang P.J. Chem. Rev. 102 (2002) 2523-2584
27. Stang P.J. J. Org. Chem. 68 (2003) 2997-3008
28. Wirth T. Top. Curr. Chem. 224 (2003) 1-264
29. Tohma H., and Kita Y. Adv. Synth. Catal. 346 (2004) 111-124
30. Moriarty R.M. J. Org. Chem. 70 (2005) 2893-2903
31. Wirth T. Angew. Chem., Int. Ed. 44 (2005) 3656-3665
32. Synthesis of quinoline derivatives in:. Herrero M.T., Tellitu I., Domínguez E., Hernández S., Moreno I., and SanMartin R. Tetrahedron 58 (2002) 8581-8589
33. Synthesis of thieno- and pyrrolo[1,4]diazepines in:. Correa A., Herrero M.T., Tellitu I., Domínguez E., Moreno I., and SanMartin R. Tetrahedron 59 (2003) 7103-7110
34. Synthesis of PBDs and heterocyclic analogues in:. Correa A., Tellitu I., Domínguez E., Moreno I., and SanMartin R. J. Org. Chem. 70 (2005) 2256-2264
35. Synthesis of pyrrolidinone derivatives in:. Serna S., Tellitu I., Domínguez E., Moreno I., and SanMartin R. Org. Lett. 7 (2005) 3073-3076
36. Correa A., Tellitu I., Domínguez E., and SanMartin R. J. Org. Chem. 71 (2006) 3501-3505
37. For reviews concerning the chemistry of nitrenium ions, see:
38. Abramovitch R.A., and Jeyaraman R. In: Scriven E.F.V. (Ed). Azides and Nitrenes: Reactivity and Utility (1984), Academic, Orlando 297-357
39. Falvey D.E. In: Moss R.A., Platz M.S., and Jones M. (Eds). Reactive Intermediate Chemistry (2004), Wiley-Interscience, Hoboken, NJ 594-650
40. Borodkin G.I., and Shubin V.G. Russ. J. Org. Chem. 41 (2005) 473-504
41. 3) cannot be ruled out.
42. Synthetic applications of these electrophilic intermediates remain limited except when such nitrenium ions are stabilized by the electron-donating effect of a proper neighboring group (aryl, alkoxy or nitrogen, inter alia). See, for example:
43. Glover S.A., Goosen A., McCleland C.W., and Schoonraad J.L. Tetrahedron 43 (1987) 2577-2592
44. Kikugawa Y., Nagashima A., Sakamoto T., Miyazama E., and Shiiya M. J. Org. Chem. 68 (2003) 6739-6744
45. Falvey D.E., and Kung A.C. J. Org. Chem. 70 (2005) 3127-3132
46. For some recent reviews on palladium-catalyzed C-N bond formation, see:
47. Muci A.R., and Buchwald S.L. Top. Curr. Chem. 219 (2002) 131-209
48. Hartwig, J. F. Synlett 2006, 1283-1294; For recent contributions of our research group in this field, see:
49. Churruca F., SanMartin R., Tellitu I., and Domínguez E. Org. Lett. 4 (2002) 1591-1594
50. Hernández S., SanMartin R., Tellitu I., and Domínguez E. Org. Lett. 5 (2003) 1095-1098
51. Carril M., SanMartin R., Churruca F., Tellitu I., and Domínguez E. Org. Lett. 7 (2005) 4787-4789
52. For a recent review on amide bond formation, see:. Montalbetti C.A.G.N., and Falque V. Tetrahedron 61 (2005) 10827-10852
53. If desired, the cyano group could be removed in an additional step to yield pyrazolone 4e. See:. Mattalia J.-M., Marchi-Delapierre C., Hazimeh H., and Chanon M. ARKIVOC iv (2006) 90-118
54. Xu L.-W., Li L., and Xia C.-G. Helv. Chim. Acta 87 (2004) 1522-1526